No, you should not take eplerenone 25 mg three times daily (TDS)
Eplerenone is dosed once or twice daily, never three times daily. The FDA-approved dosing and all major clinical guidelines consistently specify either once-daily or twice-daily administration 1.
Correct Dosing Regimens
For Heart Failure with Reduced Ejection Fraction (HFrEF)
- Initial dose: 25 mg once daily
- Target dose: 50 mg once daily (after 4 weeks if tolerated)
- Maximum dose: 50 mg once daily 2, 1
For Hypertension
- Initial dose: 50 mg once daily
- If inadequate response: 50 mg twice daily (total 100 mg/day)
- Maximum recommended: 100 mg/day (50 mg twice daily) 1
For Primary Aldosteronism
- Initial dose: 25 mg once or twice daily
- Titration: Can increase to 50 mg twice daily
- Maximum: 200-300 mg/day in divided doses 3
Why Three Times Daily Dosing Is Inappropriate
Pharmacokinetic considerations: Eplerenone has a sufficiently long half-life to maintain therapeutic effects with once or twice-daily dosing 1. Clinical trials demonstrating mortality and morbidity benefits used once-daily or twice-daily regimens, not three times daily 2, 4.
Evidence-based dosing: The landmark EPHESUS trial (post-MI heart failure) and RALES-equivalent studies used once-daily dosing of 25-50 mg 4. For hypertension, studies showed that 50 mg twice daily provided better blood pressure control than 100 mg once daily, but no evidence supports three times daily dosing 1.
If You Need 75 mg Total Daily Dose
This is an unusual total daily dose that doesn't align with standard regimens. Consider these alternatives:
- For heart failure: Stick with 50 mg once daily (the evidence-based target dose) 2
- For hypertension: Use either 50 mg once daily or 50 mg twice daily (100 mg total) 1
- If transitioning from spironolactone: Remember that eplerenone requires 2-3 times higher doses than spironolactone for equivalent effect 3
Critical Safety Monitoring
Regardless of indication, monitor:
- Potassium levels: Check at 2-3 days, 1 week, then monthly for 3 months 2
- Renal function: Same schedule as potassium
- Do not initiate if: K+ >5.0 mEq/L or eGFR <30 mL/min/1.73 m² 2
Common pitfall: Attempting to create custom dosing regimens without evidence-based support increases risk of dosing errors and suboptimal outcomes. The established once or twice-daily regimens have proven safety and efficacy profiles.